Modulatory effects of human cytomegalovirus infection on malignant properties of cancer cells

Intervirology

Volumn 39, Issue 4, 1996, Pages 259-269

  Cinatl, Jindrich ^a   Cinatl, Jaroslav ^a,b   Vogel, Jens U ^a,b   Rabenau, Holger ^a   Kornhuber, Bernhard ^b   Doerr, Hans W ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

Cytomegalovirus; Differentiation; Human; Neuroblastoma; Oncogenic potential

Indexed keywords

CELL SURFACE RECEPTOR; CYTOKINE; DOPAMINE BETA MONOOXYGENASE; GENE PRODUCT; GROWTH FACTOR; ONCOPROTEIN; RETINOIC ACID; SCLEROPROTEIN; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER CELL; CARCINOGENESIS; CELL FUNCTION; CELL MATURATION; CELL METABOLISM; CELL MOTILITY; CYTOMEGALOVIRUS INFECTION; CYTOSKELETON; DNA SEQUENCE; DNA TUMOR VIRUS; EMBRYO; ENZYME ACTIVITY; GENE EXPRESSION; GUINEA PIG; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; MALIGNANT TRANSFORMATION; MOUSE; NEURAL CREST; NEUROBLASTOMA CELL; NONHUMAN; ONCOGENE; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTO ONCOGENE; REPORTER GENE; SYRIAN HAMSTER; TUMOR GROWTH; TUMOR SUPPRESSOR GENE; VIRUS CELL TRANSFORMATION; VIRUS GENE;

ANIMALS; ANTIGENS, VIRAL; CELL TRANSFORMATION, VIRAL; CYTOMEGALOVIRUS; GENOME, VIRAL; HUMANS; IMMEDIATE-EARLY PROTEINS; MAMMALS; PHENOTYPE; TUMOR CELLS, CULTURED; VIRUS LATENCY;

EID: 0030513082     PISSN: 03005526     EISSN: 14230100     Source Type: Journal    
DOI: 10.1159/000150527     Document Type: Article

References (88)

1. Rosenthal LJ, Choudhurv S: Potential oncogenicity of human cytomegalovirus: in Becker Y, Darai G, Huang E-S (eds): Molecular Aspects of Human Cytomegalovirus Diseases, Frontiers of Virology, Berlin, Springer, 1993. vol 2. pp 412-436.
2. Huang ES, Boldogh I, Mar EC: Human cytomegaloviruses: Evidence for possible association with human cancer, in Philips LA (ed): Viruses Associated with Human Cancer, New York, Dekker, 1983. pp 161-194.
3. Koffa M, Koumantakis E, Ergazaki M, Tsat-sanis C, Spandidos DA: Association of herpesvirus infection w ith the development of genital cancer, Int J Cancer 1995:63:58-62.
4. Albrecht T, Rapp F: Malignant transformation of hamster embryo fibroblasts following exposure to ultraviolet-irradiated human cytomegalovirus, Virology 1973:55:53-61.
5. Geder L, Lausch R, O'Neill F, Rapp F: Oncogenic transformation of human embryo lung cells by human cytomegalovirus, Science 1976; 192:1134-1137.
6. Geder L, Laychock AM, Gorodccki J, Rapp F: Alterations in biological properties of different lines of cytomegalovirus-transformed human embryo lung cells following in vitro cultivation, IARC Sci Publ 1978;24:591-601.
7. Huang ES, Davis MG, Baskar JF, Huong SM: Molecular epidemiology and oncogenicity of human cytomegalovirus; in Harris CC (ed): Biochemical and Molecular Epidemiology of Cancer, New York, Liss, 1986. pp 323-344.
8. Smiley ML, Mar EC, Huang ES: Cytomegalovirus infection and viral induced transformation of human endothelial cells, J Med Virol 1988; 25:213-226.
9. Isom HC, Mummaw J, Kreider JW: Malignant transformation of guinea pig cells after exposure to ultraviolet-irradiated guinea pig cytomegalovirus, Virology 1983:126:693-700.
10. Yelle J, Dion M, Hamelin C: Distinct regions of the human cytomegalovirus genome are responsible for the immortalization and tumori-genicity of animal cells, Cancer Lett 1986:,12: 101-106.
11. Nelson JA, Fleckenstein B, Galloway DA, McDougall JK: Transformation of Nil I 3T3 cells with cloned fragments of human cytomegalovirus strain AD169. J Virol 1982;43:83-91.
12. Nelson JA, Fleckenstein B, Jahn G, Galloway DA, McDougall JK: Structureofthe transforming region of human cytomegalovirus AD 169. J Virol 1984;49:109-115.
13. Clanton DJ, Jariwalla RJ, Kress C, Rosenthal U: Neoplastic transformation by a cloned human cytomegalovirus DNA fragment uniquely homologous to one of the transforming regions of herpes simplex virus type 2. Proc Natl Acad Sci USA 1983;80:3826-3830.
14. El-Bcik T, Razzaque A, Jariwalla R, Cihlar RL, Rosenthal IJ: Multiple transformation regions of human cytomegalovirus DNA, J Virol 1986; 60:645-652.
15. Albrecht T, Boldogh I, Fons M P, Valyi-Nagy T: Activation of proto-oncogenes and cell activation signals the initiation and progression of human cytomegalovirus infection: in Becker Y, Darai G, Huang E-S (eds): Molecular Aspects of Human Cytomegalovirus Diseases, Frontiers of Virology, Berlin, Springer, 1993. vol 2. pp 384-411.
16. Jault FM, Jault JM, Ruchti F, Fortunato EA, Clark C, Corbeil J, Richman GD, Spector DH: Cytomegalovirus infection induces high levels ofeyclins, phosphorylated Rb, and p53. leading to cell cycle arrest, J Virol 1995:69:6697-6704.
17. Lamph WW, Wawsley P, Sassone-Cossi P, Vcr-ma IM: Induction of proto-oncogene Jun/Ap-1 by scrum and TPA, Nature 1988:334:629-631.
18. Michclson S, Tardy-Panit M, Barzu O: Properties of a human cytomegalovirus-induced protein kinase, Virology 1984:134:259-268.
19. Stinski MF, Macias MP, Malone CL, Thrower AB, Huang L: Regulation of transcription from the cytomegalovirus major immediate early promoter by cellular and viral proteins; in Michclson S, Plotkin SA (eds): Multidisciplinary Approach to Understanding Cytomegalovirus Disease, Amsterdam, Elsevier Science, 1993. PP 3-12.
20. Roby C, Gibson W: Characterization of phos-phoprotcins and protein kinase activity of virions, noninfcctious enveloped particles, and dense bodies of human cytomegalovirus, J Virol 1986:59:714-717.
21. Gdnczol E, Plotkin SA: Cells infected with human cytomegalovirus release a factor(s) that stimulates cell DNA synthesis, J Gen Virol 1984;65:1833-1837.
22. St. Jeor S, Admiraud J, Brucning E, Rioio J: Induction of cytokines by human cytomegalovirus; in Michclson S, Plotkin SA (eds): Multidisciplinary Approach to Understanding Cytomegalovirus Disease, Amsterdam, Elsevier Science, 1993. pp 123-126.
23. Tilg H, Vogel W, Aulitzky WB, Hcrold M, Konigsrainer A, Margreiter R, HuberC: Evaluation of cytokines and cvtokine-induced secondary messages in sera of patients after liver transplantation, Transplantation 1990:49: 1074-1080.
24. Humbert M, Dclattrc RM, Fallal S, Ccrrina J, Simonneau G, Rain B, Dartevelle P, Duroux P, Galanaud P, Emilie D: In situ production of interleukin 6 within human lung allografts displaying rejection and cytomegalovirus pneumonitis, Transplantation 1993:56:623-627.
25. Humbert M, Emilie D, Cerrina J, Simonneau G, Rain B, Lcroy-Adurie F, Fattal S, Dertevelle P, Duroux P, Galanaud P: Soluble interleukin-2 receptor and neopterin serum levels after lung/heart-lung transplantations: Absence of predictive value for late allograft rejection, Transplantation 1991; 146:1092-1094.
26. Kchrl JH, Taylor A, Kim SJ, Fauci AS: Transforming growth I'actor-beta is a potent negative regulator of human lymphocytes, Ann NY Acad Sci 1991;628:345-353.
27. Alcami J, Barzu T, Michclson S: Induction of an endothelial cell growth factor by human cytomegalovirus infection of fibroblasts, J Gen Virol 1991;72:2765-2770.
28. Crabb JW, Armes LG, Johnson CM, McKce-han WL: Characterization of multiple forms of prostatropin (prostate epithelial cell growth factor) from bovine brain, Biochem Biophys Res Commun 1986; 136:1155-1161.
29. Shing Y, Folkman J, Sullivan R, Butterfield C, Murray J, Klagsbrun M: Heparin affinity: Purification of a tumor-derived capillary endothelial cell growth factor, Science 1984:223:1296-1299.
30. Yamanaka Y, Friess H, Buchler M, Beger HG, Uchida E, Onda M, Kobrin MS: Overexpression of acidic and basic fibroblast growth factors in human pancreatic cancer correlates with advanced tumor stage, Cancer Res 1993:53: 5289-5296.
31. Wcwetzer K, Janet T, Heymann D, Unsicker K: Cell blotting and isoelectric focusing of neu-roblastoma-derivcd heparin-binding neuro-trophic activities: Detection of basic fibroblast growth factor protein and mRNA, J Neurosci Res 1993:36:209-215.
32. Spizz G, Hu J-S, Olson EN: Inhibition of myogenic differentiation by fibroblast growth factor of type B transforming growth factor does not require persistent c-nivc expression, Dev Biol 1987:123:500-507.
33. Pfeiffer G, Willutzki D, Weder D, Becker B, Radsak K: Microtubular reaction in human fibroblasts infected by cytomegalovirus, Arch Virol 1983:76:153-159.
34. Ball RL, Carney DH, Albrecht T: Taxol inhibits stimulation of cell DNA synthesis by human cytomegalovirus, Exp Cell Res 1990:191:37-44.
35. Arcangeletti MC, Missorini S, Pinardi F, Seltener K, Landini MP, Chezzi C: Cytoskcle-tal modification of human embryo fibroblasts during cytomegalovirus infection: Possible involvement of the cytoskcleton in the regulation of protein synthesis in normal and virus infected cells (abstract 63), 4th International CMV Conference, Paris, 1993. pp 18-21.
36. Pande II, Terramani T, Tressel T, Churchil MA, Hawkins GG, Zaia JA: Altered expression offibroncctin gene in cells infected with human cytomegalovirus, J Virol 1990;64:1366-1369.
37. Warren AP, Owens CN, Borysicwicz LK, Patel K: Down-regulation of inlegrin alpha 1 /ß 1 expression and association w ith cell rounding in human cytomegalovirus-infected fibroblasts, J Gen Virol 1994:75:3319-3325.
38. Grefte JMM, van der Giessen M, van Son WJ, The TH: Circulating cytomegalovirus (CMV)-infec, cd endothelial cells in patients with an active CMV infection, J Infect Dis 1993:167: 270-277.
39. Schwartz MA: Signaling by integrins: Implication for tumorigenesis, Cancer Res 1993:53: 1053-1056.
40. Warren AP, Ducroq DH, Lehncr PJ, Borysie-wiez LK: Human cytomegalovirus-infected cells have unstable assembly major histocom-pability complex class I complexes and are resistant to lysis by cytotoxie T lymphocytes, J Virol 1994:68:2822-2829.
41. Jones TR, Hanson LK, Sun L, Slater JS, Sten-berg RM, Cambell AE: Multiple independent loci within the human cytomegalovirus unique short region down-regulatc expression of major histocompatibility complex class I heavy chains, J Virol 1995:69:4830-4841.
42. Monick MM, Geist LJ, Stinski MF, Ilunning-hake GW: The immediate carlv genes of human cytomegalovirus up-regulatc expression of the cellular genes mvc and fos, Am J Respir Ceil Mol Biol 1992;7:251-256.
43. Ghazal P, Nelson JA: Transcription factors and viral regulatory proteins as potential mediators of human cytomegalovirus pathogenesis: in Becker Y, Darai G, Huang E-S (eds): Molecular Aspects of Human Cytomegalovirus Diseases, Frontiers ofVirology 2. Berlin, Springer, 1993. pp 360-383.
44. Bums LJ, Waring JF, Reuter JJ, Stinski MF, Ginder GD: Only the HLA class I gene minimal promoter elements are required for transactivation by human cytomegalovirus immediate early genes, Blood 1993;81:1558-1566.
45. Hagemeicr C, Walker SM, Sissons PJG, Sinclair JH: The 72K IEI and 80K IF,2 proteins of human cytomegalovirus independently trans-activate the c-fos, c-myc and hsp70 promoters via basal promoter elements, J Gen Virol 1992: 73:2385-2393.
46. Iwamoto GK, Monick MM, Clark BD, Auron PE, Stinski MF, HunnighakeGW: Modulation of interleukin 1 beta gene expression by the immediate early genes of human cytomegalovirus, J Clin Invest 1990:85:1853-1857.
47. Wade M, Kowalik TF, Mudryj M, Huang E-S, Azizkhan JO: E2F mediates dihydrofolate reductase promoter activation and multiprotein complex formation in human cytomegalovirus infection, Mol Cell Biol 1992; 12:4364-4374.
48. Lukac DM, Manuppcllo JR, Alwine JC: Transcriptional activation by the human cytomegalovirus immediate-early proteins: Requirements for simple promoter structures and interactions with multiple components of the transcription complex, J Virol 1994:68:5184-5193.
49. Jenkins DE, Martens CL, Mocarski F, S: Human cytomegalovirus late protein encoded by IE2: A trans-activator as well as repressor of gene expression, J Gen Virol 1994:75:2337-2348.
50. Sen R, Baltimore D: Multiple nuclear factors interact with the immunoglobulin enhancer sequences, Cell 1986:46:705-716.
51. Huang ES, Kowalik TF: The pathogenicity of human cytomegalovirus: An overview: in Becker Y, Darai G, Huang E-S (eds): Molecular Aspects of Human Cytomegalovirus Diseases, Frontiers of Virology 2. Berlin, Springer, 1993. pp 3-45.
52. Yurochko AD, Kowalik TF, Huong SM, Huang ES: Human Cytomegalovirus up-regulatcs NF-kB activity by transactivatingthe NF-kB pl()5/ p50 and p65 promoters, J Virol 1995:69:5391-5400.
53. Michelson S, Aicami J, Kim SJ, Danielpour D, Bachclcric F, Picard L, Bessia C, Paya C, Vire-lizicr JL: Human cytomegalovirus infection induces transcription and secretion oftransform-inggrowth factor beta I, J Virol 1994:68:5730-5737.
54. Woodroffe SB, Garnett HM, Danis VA, Layton JE: Alteration in 1L-I alpha and IL-1 beta, G-C'SF and GM-C'SF secretion by endothelial cells infected with a clinical isolate of CMV: in Michelson S, Plotkin SA (eds): Multidisciplinary Approach to Understanding Cytomegalovirus Disease, Amsterdam, Elsevier Science, 1993. pp 117-122.
55. Huang ES: Human cytomegalovirus, III, Virus-induced DNA polymerase, J Virol 1975; 16: 298-310.
56. Estes JE, Huang ES: Stimulation of cellular thymidine kinases by human cytomegalovirus, J Virol 1975:24:13-21.
57. Tanaka S, lhara S, Watanabc Y: Human cytomegalovirus induces DNA-dependent RNA polymerases in human diploid cells, Virology 1978:89:179-185.
58. Benson JD, Huang ES: Human cytomegalovirus induces expression of cellular topoisomer-ase II, J Virol 1990:64:9-15.
59. Margolis MJ, Pajovie S, Wong EL, Wade M, Jupp R, Nelson JA, Azizkhan JC: Interaction of the 72-kilodalton human cytomegalovirus IE1 gene product with E2FI coincides with E2F-dependcnt activation of dihydrofolate reductase transcription, J Virol 1995:69:7759-7767.
60. Speir E, Modali R, Huang ES, Leon MB, Shawl F, l-inkel T, Epstein SE: Potential role of human cytomegalovirus and p53 interactions in coronary restenosis, Science 1994:265:391-394.
61. I lagemcicr C, Caswell R, I layhurst G, Sinclair J, Kouzarides T: Functional interaction between the HCMV 1E2 transactivator and the retinoblastoma protein, EMBO J 1994:13: 2897-2903.
62. Shen Y, Shenk T: Viruses and apoptosis, Curr Opin Genet Dev 1995:5:105-111.
63. Zhu H, Shen Y, Shenk T: Human cytomegalovirus IE I and 1E2 proteins block apoptosis, J Virol 1995:69:7960-7970.
64. Wyatt JP, Saxton J, Lee RS, Pinkerton H: Generalized cytomegalic inclusion disease, J Pe-diatr 1950:1-294.
65. Doerr HW, Braun R, Munk K: Human cytomegalovirus infection: Recent developments in diagnosis and epidemiology, Klin Wochcnschr 1985:63:241-251.
66. Toorkey CB, Carrigan DR: Immunohisto-chemical detection of an immediate early antigen of human cytomegalovirus in normal tissues, J Infect Dis 1989:160:741-751.
67. Smith JD: Human cytomegalovirus: Demonstration of permissive epithelial cells and non-permissive fibroblastic cells in a survey of human cell lines, J Virol 1986:60:583-588.
68. Cooper NR, Nowlin D, Taylor HP, Compton D: Cellular receptor for human cytomegalovirus, Transplant Proc 1991:23(suppl 3):56-59.
69. Wright JF, Kurosky A, Pryzdial ELG, Wasi S: Host cellular annexin II associated with cytomegalovirus particles isolated from cultured human fibroblasts, J Virol 1995:69:4784-4791.
70. Radsak K, Fuhrmann R, Franke RP, Schneider D, Kollert A, Briicher KA, Drcnckhahn D: Induction by sodium butyrate of cytomegalovirus replication in human endothelial cells, Arch Virol 1989:107:151-158.
71. Furukawa T: A variant of human cytomegalovirus derived from a persistently infected culture, Virology 1984;137:191-194.
72. Gonezol E, Andrews PW, Plotkin SA: Cytomegalovirus replicates in differentiated but not in undifferentiated human embryonal carcinoma cells, Science 1984:254:156-161.
73. Ogura T, Tanaka J, Kantiya S, Sato H, Ogura H, Hatano M: Human cytomegalovirus persistent infection in a human central nervous system cell line: Production of a variant virus with different growth characteristics, J Gen Virol 1986:67:2605-2616.
74. Poland SD, Costello P, Dckaban GA, Rice GPA: Cytomegalovirus in the brain: In vitro infection of human brain derived cells, J Infect Dis 1990:162:1252-1262.
75. Wcinshcnkcr BG, Wilton S, Rice GPA: Phor-bol ester-induced differentiation permits productive human cytomegalovirus infection in a monocytic cell line, J Immunol 1988:140: 1625-1631.
76. Nelson JA, Groudine M: Transcriptional regulation of the human cytomegalovirus major immediate-early gene is associated with induction DNase I hypersensitive sites, Mol Cell Biol 1986;6:452-461.
77. Sinclair JM, Baillic J, Bryant LA, Taylor-Wiedeman JA, Sissons JGP: Repression of human cytomegalovirus major immediate early gene expression in a monocytic cell line, J Gen Virol 1992:73:433-435.
78. Shapiro DN, Houghton PJ, Hazelton BJ, Germain GS, Murti KG, Rahman A, Houghton JA: Morphological and molecular characterization of spontaneous myogenic differentiation in a human rhabdomyosarcoma cell line, Cancer Res 1990;50:6002-6009.
79. Tsokos M, Scarpa S, Ross RA, Triche TJ: Differentiation of human neuroblastoma recapitulates neural crest development, Am J Pathol 1987:128:484-496.
80. Cinatl J Jr, Cinatl J, Mainke M, Weissflog A, Rabenau H, Kornhubcr B, Doerr HW: In vitro differentiation of human neuroblastoma cells induced by sodium phcnvlacctate, Cancer Lett 1993:70:15-24.
81. Cinatl J Jr, Cinatl J, Mainke M, Weissfiog A, Steigmann G, Rabenau H, Doerr HW, Komhuber B: Aphidicolin selectively kills neuroblastoma cells in vitro, Cancer Lett 1992:67: 199-206.
82. Cinatl J Jr, Cinatl J, Hernaiz Driever P, Rabenau H, Novak M, Benda R, Ciümbcl HO, Komhuber B, Doerr HW: Induction of myogenic differentiation in a human rhabdomyosarcoma cell line by phenylacelate, Cancer Lett 1994:78:41-48.
83. Cinatl J Jr, Cinatl J, Radsak K, Rabenau H, Weber B, Novak M, Benda R, Komhuber B, Doerr HW: Replication of human cytomegalovirus in a rhabdomyosarcoma cell line depends on the state of differentiation of the cells, Arch Virol 1994:138:391-401.
84. Woll D, Sinzger C, Drescher P, Jahn G, Plach-ter B: Reduced levels of IE2 gene expression and shut down of early and late viral genes during latent infection of the glioblastoma cell line U138-MG with selectable recombinants of human cytomegalovirus, J Virol 1994,204:101-113.
85. Cinatl J Jr, Vogel J-U, Cinatl J, Weber B, Rabenau H, Novak M, Komhuber B, Doerr HW: Long-term productive human cytomegalovirus infection of a human neuroblastoma cell line, Int J Cancer 1996:63:1-7.
86. Seegcr RC, Brodeur GM, Salher H, Dalton A, Siegd SE, Wong KY, Hammond D: Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas, N Engl J Med 1985;313:1111-1116.
87. Fcrrandis E, Da Silva J, Riou G, Bernard I: Coactivation of the MDR-I, MYCN genes in human neuroblastoma cells during the metastatic process in the nude mouse, Cancer Res 1994.54:2256-2261.
88. Bolandc RP: Spontaneous regression and cy-todifferentiation of cancer in early life: The oncogenic grace period, Surv Synth Pathol Res 1985.4:296-311.